Breathtec BioMedical Inc.

(BTH:CNX)

By |
Breathtec BioMedical Inc.

Profile

Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.

Issuer Information

Exchange: CNQ
CEO: Guy LaTorre
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: In-Vitro Diagnos
$ 0.33 $ -0.005 (-1.49%)
Last Price 0.33 Change $ -0.005 Change % -1.49 Tick N/A
Bid 0.33 Bid Size 3,500.00 Ask 0.34 Ask Size 32,000.00
Open 0.33 High 0.34 Low 0.33 Prev Close 0.34
Last Trade Volume 373,169 52 Wk Hi 0.52 52 Wk Low 0.065
Market Cap 18.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,752,024.00 EPS (TTM) -0.04 PE Ratio N/A Exchange CSE

News